GTx (United States)
GTx, Inc. was a pharmaceutical company working on drugs in the selective estrogen receptor modulator and selective androgen receptor modulator classes. Its drugs in development included enobosarm and GTx-758. The company was founded in Memphis in 1997 by Mitch Steiner and Marc S. Hanover. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for GTx (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
23%
Total
Publications
26K
Total Open
Publications
6K
Total
Citations
1M
Open Access
Percentage
23%
Total
Publications
26K
Total Open
Publications
6K
Total
Citations
1M
Breakdown
Publisher Open
12%
Both
5%
Other Platform Open
8%
Closed
75%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
1.8K
Hybrid 26%
1.2K
No Guarantees 35%
1.6K
Other Platform Open
Domain 60%
2.2K
Institution 28%
1K
Other Internet 18%
675
Public 1%
52
Preprint 1%
47
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 2.2K |
DOI | Other Internet | 661 |
Royal Netherlands Academy of Arts and Sciences | Institution | 176 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 76 |
Europe PMC | Domain | 71 |
uj.edu.pl OAI-PMH Repository | Institution | 55 |
University of Modena and Reggio Emilia | Institution | 50 |
Zenodo | Public | 40 |
Yonsei University | Institution | 38 |
Research Square | Preprint | 38 |